Bahrain vs Palestine: Share of the population living with HIV receiving antiretroviral
Bahrain
55.0%
in 2024
Palestine
58.4%
in 2024
Bahrain rank
117th
Palestine rank
114th
Share of the population living with HIV receiving antiretroviral over time
- Bahrain
- Palestine
How they compare
Palestine currently reports 58.4% against 55.0% in Bahrain, a difference of 3.4%.
That makes Palestine's figure about 1.1 times Bahrain's.
The two have swapped places 4 times across 35 shared years of data; in 1990 it was Palestine ahead.
Bahrain ranks 117th and Palestine ranks 114th of 149 countries.
Across the 4 decades both report, Bahrain averaged higher in 2 and Palestine in 1.
Head to head by decade
| Decade | Bahrain | Palestine | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0.0% | 0.0% | 0.0% | — |
| 2000s | 14.1% | 3.5% | 10.6% | Bahrain |
| 2010s | 35.4% | 33.2% | 2.2% | Bahrain |
| 2020s | 55.3% | 57.9% | 2.6% | Palestine |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of the population living with hiv receiving antiretroviral therapy, Bahrain or Palestine?
- Palestine, at 58.4% against 55.0% in Bahrain as of 2024.
- What is the difference in share of the population living with hiv receiving antiretroviral therapy between Bahrain and Palestine?
- 3.4%, with Palestine ahead.
- How many years of comparable data are there for Bahrain and Palestine?
- 35 years are reported by both, from 1990 to 2024.
- How do Bahrain and Palestine rank globally for share of the population living with hiv receiving antiretroviral therapy?
- Bahrain ranks 117th and Palestine ranks 114th of 149 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as Share of the population living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.